Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextrose Prolotherapy for Myofascial Pain Syndrome
NCT04941118Phase 4Unknown
- Sponsor
- Hatay Mustafa Kemal University
- Start
- Jul 2021
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of dextrose in myofascial pain syndrome (MPS) (2 arms), sponsored by Hatay Mustafa Kemal University. Primary endpoints: Visual Analog Scale at 1 month, Neck Disability Index at 1 month and 1 more. Status: unknown.
02
Drugs
dextrose
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT04941118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04941118.